FDA Brief

Warning letters Drugs

FDA warning letter to

Ketamine Troche Store / www.ketaminetrochestore.com

High riskIssued Jun 23Posted Jul 7Center for Drug Evaluation and Research (CDER)

FDA warned online seller Ketamine Troche Store that its website sells unapproved, misbranded ketamine drugs without prescriptions.

What happened

FDA reviewed the website www.ketaminetrochestore.com from January 9 to January 16, 2026, and found ketamine and esketamine products offered for sale with claims to treat depression, anxiety, and chronic pain. The products named were "Ketamine Liquid," "Ketamine Suppository," "Ketamine Nasal Spray" (esketamine), and "Ketamine 100 mg Troche." FDA said none of these has an FDA-approved application, and that the site sells them without requiring a prescription.

What FDA found

  1. The company sells ketamine drugs that have no FDA-approved application, which the law calls unapproved new drugs.

    FD&C Act sections 505(a) and 301(d) (21 U.S.C. 355(a), 331(d))
  2. The "Ketamine 100 mg Troche" is sold without prescriptions for individual patients and the seller is not a registered outsourcing facility, so it does not qualify for the compounding exemptions.

    FD&C Act sections 503A and 503B (21 U.S.C. 353a, 353b); sections 505(a) and 301(d)
  3. The product labels do not give adequate directions for use, which prescription drugs cannot have for a layperson, so the drugs are misbranded.

    FD&C Act section 502(f)(1) (21 U.S.C. 352(f)(1))
  4. The site offers prescription drugs without requiring a prescription from a licensed practitioner, which misbrands the drugs.

    FD&C Act sections 503(b)(1) and 301(k) (21 U.S.C. 353(b)(1), 331(k))

What FDA wants

FDA tells the company to stop offering any unapproved and misbranded drugs for sale to U.S. consumers, and to send a written response within 15 business days describing the corrections, how it will prevent repeat violations, and supporting documents.

Who should pay attention

  • online and telehealth sellers of ketamine products
  • pharmacies and compounders that supply ketamine troches or liquids
  • clinics and brands whose ketamine products could be resold through third-party websites

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk